SEC Form 4 · accession 0001179110-18-001608
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Beth Taylor
Officer — VP Finance & Chief Acctg Offcr
Period of report
Feb 2, 2018
Accepted (ET)
Feb 6, 2018 · 12:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 2, 2018 | F | 890 | $3.12 | D | 60,393 | D | |
| Common StockF2 | Feb 4, 2018 | F | 869 | $3.12 | D | 59,524 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 2,500 restricted stock units in the form of Company common stock on a one-for-one basis on February 2, 2018.
- F2Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 938 and 1,500 restricted stock units in the form of Company common stock on a one-for-one basis on February 4, 2018.